MBX Biosciences
MBX
$10.60
Share price
-4.39%
Change (1 day)
N/A
Change (1 year)
Categories
MBX Biosciences (MBX) - Cash on Hand
Cash on Hand as of December 2024 : C$0.37 Billion
According to MBX Biosciences's latest financial reports the company has C$0.37 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
MBX Biosciences - Cash on Hand chart (from 2023 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | C$0.37 B | 251.55% |
| 2023-12-31 | C$0.10 B | 85.72% |
| 2022-12-31 | C$57.61 M |